{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:29:34Z","timestamp":1759177774082,"version":"3.40.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.mayocp.2022.10.028","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:21:08Z","timestamp":1671538868000},"page":"533-540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cardiovascular Risk and Diseases in Patients With and Without Leptin-Melanocortin Pathway Variants"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7865-2947","authenticated-orcid":false,"given":"Lizeth","family":"Cifuentes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6294-8652","authenticated-orcid":false,"given":"Alejandro","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Sacoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9389-6795","authenticated-orcid":false,"given":"Wissam","family":"Ghusn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"De la Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2382-3240","authenticated-orcid":false,"given":"Fauzi","family":"Feris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"McRae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua T.","family":"Bublitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria D.","family":"Hurtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2286-489X","authenticated-orcid":false,"given":"Andres","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mayocp.2022.10.028_bib1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1514009","article-title":"Mechanisms, pathophysiology, and management of obesity","volume":"376","author":"Heymsfield","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"10113","key":"10.1016\/j.mayocp.2022.10.028_bib2","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults","volume":"390","author":"Abarca-G\u00f3mez","year":"2017","journal-title":"Lancet"},{"issue":"7121","key":"10.1016\/j.mayocp.2022.10.028_bib3","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature05487","article-title":"Mechanisms linking obesity with cardiovascular disease","volume":"444","author":"Van Gaal","year":"2006","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.mayocp.2022.10.028_bib4","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1161\/CIRCULATIONAHA.106.176583","article-title":"Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association","volume":"113","author":"Eckel","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mayocp.2022.10.028_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/oby.21381","article-title":"NIH working group report\u2014using genomic information to guide weight management: from universal to precision treatment","volume":"24","author":"Bray","year":"2016","journal-title":"Obesity (Silver Spring)"},{"issue":"10","key":"10.1016\/j.mayocp.2022.10.028_bib6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ncpendmet0966","article-title":"Mutations in ligands and receptors of the leptin-melanocortin pathway that lead to obesity","volume":"4","author":"Farooqi","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mayocp.2022.10.028_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cell.2015.03.008","article-title":"The hunger genes: pathways to obesity","volume":"161","author":"van der Klaauw","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mayocp.2022.10.028_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/jc.2004-0497","article-title":"Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity","volume":"90","author":"Larsen","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6778","key":"10.1016\/j.mayocp.2022.10.028_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mayocp.2022.10.028_bib10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/01.HYP.0000175474.99326.bf","article-title":"Melanocortin-4 receptor\u2013deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia","volume":"46","author":"Tallam","year":"2005","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.mayocp.2022.10.028_bib11","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1097\/01.hjh.0000249702.49854.fa","article-title":"Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones","volume":"24","author":"Ni","year":"2006","journal-title":"J\u00a0Hypertens"},{"issue":"11","key":"10.1016\/j.mayocp.2022.10.028_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032707","article-title":"Characteristics and utilisation of the Mayo Clinic Biobank, a clinic-based prospective collection in the USA: cohort profile","volume":"9","author":"Olson","year":"2019","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.mayocp.2022.10.028_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003206","article-title":"Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: a systematic review and meta-analysis","volume":"17","author":"Wiggins","year":"2020","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.mayocp.2022.10.028_bib14","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"4","key":"10.1016\/j.mayocp.2022.10.028_bib15","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1210\/jc.2009-2297","article-title":"Sympathetic function in human carriers of melanocortin-4 receptor gene mutations","volume":"95","author":"Sayk","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mayocp.2022.10.028_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa0803085","article-title":"Modulation of blood pressure by central melanocortinergic pathways","volume":"360","author":"Greenfield","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.mayocp.2022.10.028_bib17","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.cell.2014.10.058","article-title":"Leptin mediates the increase in blood pressure associated with obesity","volume":"159","author":"Simonds","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.mayocp.2022.10.028_bib18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/01.HYP.0000111836.54204.93","article-title":"Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation","volume":"43","author":"Kuo","year":"2004","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.mayocp.2022.10.028_bib19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/01.HYP.0000052314.95497.78","article-title":"The kidney, hypertension, and obesity","volume":"41","author":"Hall","year":"2003","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.mayocp.2022.10.028_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-7435(87)90087-9","article-title":"Incidence and precursors of hypertension in young adults: the Framingham Offspring Study","volume":"16","author":"Garrison","year":"1987","journal-title":"Prev Med"},{"issue":"1","key":"10.1016\/j.mayocp.2022.10.028_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/01.HYP.26.1.60","article-title":"Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991","volume":"26","author":"Burt","year":"1995","journal-title":"Hypertension"},{"issue":"23","key":"10.1016\/j.mayocp.2022.10.028_bib22","doi-asserted-by":"crossref","first-page":"17271","DOI":"10.1074\/jbc.R110.113175","article-title":"Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins","volume":"285","author":"Hall","year":"2010","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.mayocp.2022.10.028_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/vhrm.2006.2.2.163","article-title":"Leptin and hypertension in obesity","volume":"2","author":"Bravo","year":"2006","journal-title":"Vasc Health Risk Manag"},{"issue":"4","key":"10.1016\/j.mayocp.2022.10.028_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.HYP.0000032940.33466.12","article-title":"Obesity hypertension in children: a problem of epidemic proportions","volume":"40","author":"Sorof","year":"2002","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.mayocp.2022.10.028_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S1368980010001813","article-title":"The duration of obesity and the risk of type 2 diabetes","volume":"14","author":"Abdullah","year":"2011","journal-title":"Public Health Nutr"},{"issue":"3","key":"10.1016\/j.mayocp.2022.10.028_bib26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/oxfordjournals.aje.a009800","article-title":"Association between duration of obesity and risk of non-insulin-dependent diabetes mellitus: the Sotetsu Study","volume":"149","author":"Sakurai","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.mayocp.2022.10.028_bib27","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2337\/diacare.22.8.1266","article-title":"Weight change and duration of overweight and obesity in the incidence of type 2 diabetes","volume":"22","author":"Wannamethee","year":"1999","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2022.10.028_bib28","doi-asserted-by":"crossref","first-page":"i74","DOI":"10.1093\/ije\/dyv097.279","article-title":"Duration of obesity and incident hypertension in adults from the Framingham Heart Study","volume":"44","author":"Tanamas","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"8","key":"10.1016\/j.mayocp.2022.10.028_bib29","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/ajh\/7.8.772","article-title":"Resistance to metabolic actions of insulin and its role in hypertension","volume":"7","author":"Hall","year":"1994","journal-title":"Am J Hypertens"},{"issue":"7","key":"10.1016\/j.mayocp.2022.10.028_bib30","article-title":"Association of insulin resistance, plasma glucose level, and serum insulin level with hypertension in a population with different stages of impaired glucose metabolism","volume":"9","author":"Sasaki","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.mayocp.2022.10.028_bib31","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1210\/endo.141.9.7665","article-title":"The central melanocortin system can directly regulate serum insulin levels","volume":"141","author":"Fan","year":"2000","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.mayocp.2022.10.028_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2019.03.044","article-title":"Human gain-of-function MC4R variants show signaling bias and protect against obesity","volume":"177","author":"Lotta","year":"2019","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.mayocp.2022.10.028_bib33","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa022050","article-title":"Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene","volume":"348","author":"Farooqi","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.mayocp.2022.10.028_bib34","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4065\/82.8.927","article-title":"Diagnosis of obesity by primary care physicians and impact on obesity management","volume":"82","author":"Bardia","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.mayocp.2022.10.028_bib35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1089\/pop.2017.0092","article-title":"Use of International Classification of Diseases, Ninth Revision codes for obesity: trends in the United States from an electronic health record\u2013derived database","volume":"21","author":"Mocarski","year":"2018","journal-title":"Popul Health Manag"},{"issue":"2","key":"10.1016\/j.mayocp.2022.10.028_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cjca.2014.08.004","article-title":"Obesity and the obesity paradox in heart failure","volume":"31","author":"Gupta","year":"2015","journal-title":"Can J Cardiol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.10.028_bib37","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1053\/j.ajkd.2013.07.021","article-title":"Effect of age and dialysis vintage on obesity paradox in long-term hemodialysis patients","volume":"63","author":"Vashistha","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2022.10.028_bib38","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cjca.2017.10.025","article-title":"Structural bias in studies of cardiovascular disease: let's not be fooled by the \u201cobesity paradox","volume":"34","author":"Stovitz","year":"2018","journal-title":"Can J Cardiol"},{"issue":"10","key":"10.1016\/j.mayocp.2022.10.028_bib39","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1161\/01.CIR.0000157740.93598.51","article-title":"Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: executive summary","volume":"111","author":"Yancy","year":"2005","journal-title":"Circulation"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622006425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622006425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T16:30:03Z","timestamp":1680798603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619622006425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0025619622006425"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.10.028","relation":{},"ISSN":["0025-6196"],"issn-type":[{"type":"print","value":"0025-6196"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Risk and Diseases in Patients With and Without Leptin-Melanocortin Pathway Variants","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}